Assessing Cancer Risks from Short‐Term Exposures in Children

For the vast majority of chemicals that have cancer potency estimates on IRIS, the underlying database is deficient with respect to early-life exposures. This data gap has prevented derivation of cancer potency factors that are relevant to this time period, and so assessments may not fully address children's risks. This article provides a review of juvenile animal bioassay data in comparison to adult animal data for a broad array of carcinogens. This comparison indicates that short-term exposures in early life are likely to yield a greater tumor response than short-term exposures in adults, but similar tumor response when compared to long-term exposures in adults. This evidence is brought into a risk assessment context by proposing an approach that: (1) does not prorate children's exposures over the entire life span or mix them with exposures that occur at other ages; (2) applies the cancer slope factor from adult animal or human epidemiology studies to the children's exposure dose to calculate the cancer risk associated with the early-life period; and (3) adds the cancer risk for young children to that for older children/adults to yield a total lifetime cancer risk. The proposed approach allows for the unique exposure and pharmacokinetic factors associated with young children to be fully weighted in the cancer risk assessment. It is very similar to the approach currently used by U.S. EPA for vinyl chloride. The current analysis finds that the database of early life and adult cancer bioassays supports extension of this approach from vinyl chloride to other carcinogens of diverse mode of action. This approach should be enhanced by early-life data specific to the particular carcinogen under analysis whenever possible.

[1]  S. Patierno,et al.  Preferential formation and repair of chromium-induced DNA adducts and DNA--protein crosslinks in nuclear matrix DNA. , 1994, Carcinogenesis.

[2]  L. L. Smith,et al.  Tamoxifen associated uterine pathology in rodents: relevance to women. , 1996, Carcinogenesis.

[3]  W. Branham,et al.  Endometrial hyperplasia and apoptosis following neonatal diethylstilbestrol exposure and subsequent estrogen stimulation in both host and transplanted hamster uteri. , 1997, Cancer research.

[4]  R. Liebelt,et al.  HORMONAL INFLUENCES ON URETHAN CARCINOGENESIS IN C3H/F MICE. , 1964, Cancer research.

[5]  I. White,et al.  Tamoxifen induces endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia. , 2000, Carcinogenesis.

[6]  T. Goldsworthy,et al.  Loss of tumor-promoting activity of unleaded gasoline in N-nitrosodiethylamine-initiated ovariectomized B6C3F1 mouse liver. , 1997, Carcinogenesis.

[7]  B. Tóth.  A critical review of experiments in chemical carcinogensis using newborn animals. , 1968, Cancer research.

[8]  M. Salmona,et al.  Liver DNA alkylation after a single carcinogenic dose of dimethylnitrosamine to newborn and adult CFW Swiss mice. , 1988, Chemico-biological interactions.

[9]  K. Rao,et al.  Conditions modifying development of tumors in mice at various sites by benzo(a)pyrene. , 1975, Cancer research.

[10]  J. Russo,et al.  Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. , 1979, The American journal of pathology.

[11]  H. Bolt,et al.  The rat liver foci bioassay: I. Age-dependence of induction by vinyl chloride of ATPase-deficient foci. , 1985, Carcinogenesis.

[12]  M Pelekis,et al.  Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds. , 2001, Regulatory toxicology and pharmacology : RTP.

[13]  G. Gass,et al.  CARCINOGENIC DOSE-RESPONSE CURVE TO ORAL DIETHYLSTILBESTROL. , 1964, Journal of the National Cancer Institute.

[14]  N. Tretyakova,et al.  Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene. , 1999, Chemical research in toxicology.

[15]  L. Anderson,et al.  Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice. , 1999, Toxicology and applied pharmacology.

[16]  D. L. Greenman,et al.  Estrogen-induced thyroid follicular cell adenomas in C57BL/6 mice. , 1990, Journal of toxicology and environmental health.

[17]  K Fujii.  Evaluation of the newborn mouse model for chemical tumorigenesis. , 1991, Carcinogenesis.

[18]  L. Anderson,et al.  Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. , 2000, Environmental health perspectives.

[19]  D. Hattis,et al.  Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  T. Goldsworthy,et al.  Interactive effects of unleaded gasoline and estrogen on liver tumor promotion in female B6C3F1 mice. , 1994, Cancer research.

[21]  J. Thomale,et al.  Differential formation and repair of the mutagenic DNA alkylation product O6-ethylguanine in transcribed and nontranscribed genes of the rat. , 1994, The Journal of biological chemistry.

[22]  T. Slaga,et al.  Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice. , 1997, Carcinogenesis.

[23]  M. Festing,et al.  DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation. , 1995, Carcinogenesis.

[24]  J. Engelbergs,et al.  Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Bartsch,et al.  Increased alkylation of liver DNA and cell turnover in young versus old rats exposed to vinyl chloride correlates with cancer susceptibility. , 1989, Toxicology letters.

[26]  A. Ito,et al.  Effect of age at treatment on the incidence and location of neurogenic tumors induced in Wistar rats by a single dose of N-ethyl-N-nitrosourea. , 1981, Gan.

[27]  K. Rao,et al.  Carcinogenicity of diethylnitrosamine in newborn, infant, and adult mice , 2004, Journal of Cancer Research and Clinical Oncology.

[28]  D W Gaylor,et al.  A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. , 1998, Carcinogenesis.

[29]  S. Odashima.  Overview: N-nitroso compounds as carcinogens for experimental animals and man. , 1980, Oncology.

[30]  P. Fu,et al.  Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay. , 1997, Regulatory toxicology and pharmacology : RTP.

[31]  J. Haseman,et al.  The effect of age and exposure duration on cancer induction by a known carcinogen in rats, mice, and hamsters. , 1983, Toxicology and applied pharmacology.

[32]  T. Goldsworthy,et al.  Expression of myc, fos and Ha‐ras associated with chemically induced cell proliferation in the rat liver , 1994, Cell proliferation.

[33]  R C Garner,et al.  The role of DNA adducts in chemical carcinogenesis. , 1998, Mutation research.

[34]  R. C. Shank,et al.  Hydrazine genotoxicity in the neonatal rat. , 1994, Toxicology and applied pharmacology.

[35]  T. Kasuga,et al.  Induction of hepatocellular tumor by x-ray irradiation at perinatal stage of mice. , 1978, Gan.

[36]  T. Nomura.  Comparison of tumour susceptibility among various organs of foetal, young and adult ICR/Jcl mice. , 1976, British Journal of Cancer.

[37]  J. McLachlan,et al.  Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. , 1990, Cancer research.

[38]  E. Luebeck,et al.  Incorporating cell proliferation kinetics into models for cancer risk assessment. , 1995, Toxicology.

[39]  D. Meranze,et al.  Effect of age and sex on the development of neoplasms in wistar rats receiving a single intragastric instillation of 7,12‐dimethylbenz(a)anthracene , 1969 .

[40]  G. Wogan,et al.  Quantitation of aflatoxin B1 adduction within the ribosomal RNA gene sequences of rat liver DNA. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A G Renwick,et al.  Toxicokinetics in infants and children in relation to the ADI and TDI. , 1998, Food additives and contaminants.

[42]  I. London,et al.  Transient inhibition of protein synthesis induces expression of proto‐oncogenes and stimulates resting cells to enter the cell cycle , 1995, Cell proliferation.

[43]  R. Newbold,et al.  Uterine carcinoma in mice treated neonatally with tamoxifen. , 1997, Carcinogenesis.

[44]  M. Legator.  Underestimating Risk for Three Important Human Carcinogens: Vinyl Chloride, Benzene, and Butadiene , 1997, Annals of the New York Academy of Sciences.

[45]  Harvey J Clewell,et al.  Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  H. Rappaport,et al.  The effects of carcinogenic chemicals in newborn mice , 1961, Cancer.

[47]  C. Schmidt.  Childhood cancer: A growing problem. , 1998, Environmental health perspectives.

[48]  T. Harris,et al.  CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice , 1997, Molecular and cellular biology.

[49]  D W Gaylor,et al.  Tumors and DNA adducts in mice exposed to benzo[a]pyrene and coal tars: implications for risk assessment. , 1998, Environmental health perspectives.

[50]  C. Maltoni,et al.  Carcinogenicity bioassays of vinyl chloride monomer: a model of risk assessment on an experimental basis. , 1981, Environmental health perspectives.

[51]  K Walton,et al.  An analysis of the need for an additional uncertainty factor for infants and children. , 2000, Regulatory toxicology and pharmacology : RTP.